Welcome Our Team Track Record Useful Links News Contact

News 16/10/2006  - Foamix and Taro Enter License Agreement for the Development and Commercialization of Foamix's PerFoam™ 1% for the Treatment of Head Lice     16/08/2006  - Globes: Foamix displays its wares     24/07/2006  - Foamix Announces New Waterless Foam Designed for Enhanced Skin Delivery - Useful for Steroids and Water Sensitive Drugs     20/07/2006  - Foamix’s Betamethasone Foam Demonstrates High Efficacy in Psoriasis Treatment and 85% Better Usability than Cream in Phase I/II Study     17/07/2006  - Foamix Names David Schuz as Senior Vice President, Intellectual Property     06/03/2006  - Foamix LTD is featured in Bioexecutive International, March 2006     29/04/2006  - Foamix CEO to Present “The Changing Face of Dermatology” at the Bio Business Forum at Bio International 2006 in Chicago, April 10, 2006     07/02/2006  - Foamix Receives Patents for OilGel™ In the U.S. and in Australia     02/12/2005  - Cosmeticsdesign.com: Foamix granted US patent for OilGel     28/11/2005  - LEO and Foamix to Develop Two New Medicated Foams for the Treatment of Psoriasis     28/11/2005  - Foamix Granted Third U.S. Patent for OilGel™, In Development for Dermatological and Ophthalmic Applications     03/11/2005  - Foamix Executive Director Dr. Stanley Hirsch to Present Foamix - Innovative Delivery in Dermatology at Bio-Europe 2005, November 8th at 8:30 a.m.     22/09/2005  - New Foam Product for the Treatment of Scabies: A Development Collaboration by Stiefel Laboratories, Inc. of the USA and Foamix Ltd. of Israel     11/09/2005  - Foamix to Showcase Emulsion-Based Cosmetic Foams at The Health and Beauty America (HBA) Conference in New York     11/09/2005  - Foamix Commences Phase II Study of TerbiFoam™ 2% Foam for the Treatment of Athlete’s Foot. Company Concurrently Conducts Phase II Study of Betamethasone 0.12% Emollient Foam for the Treatment of Psoriasis     22/08/2005  - Drug Topics: Are new lice treatments up to scratch?     19/07/2005  - Foamix lice treatment demonstrates 96% efficacy in Phase II/III study     18/07/2005  - Foamix’s PerFoam™ for the Treatment of Lice Demonstrates Safety and 96% Efficacy in Phase II/III Study     04/07/2005  - in-Pharma Technologist.com: Topical Drug Delivery Gel Patented by Foamix     08/06/2005  - Foamix Selected to Present at the Bio Business Forum at Bio International 2005 in Philadelphia in June     05/06/2005  - ISRAEL21C: Foam - the Israeli way to take the sting out of skin treatments     01/06/2005  - MarketWatch: Israel's Foamix eyes U.S. IPO in next 18 months     26/05/2005  - Globes article dated May 26, 2005: Drug Delivery Technology co Foamix raising $5m     02/06/2005  - Foamix "Breaks the Ribbon" on New Facility     02/04/2005  - Foamix Unveils Unique Mupirocin Foam     02/06/2004  - Foamix Unveils Innovative Vaginal Foam     02/04/2004  - Frost & Sullivan alert dated April 2, 2004: A new trend in dermatological drug delivery: foamy carriers     01/10/2003  - Jerusalem Post dated October 1, 2003: The future is in foam     03/08/2003  - Globes article dated August 3, 2003: All Froth     15/09/2003  - Phase II Psoriasis Study Approved     10/06/2003  - Foamix Unveils Revolutionary Dermatological Foams     10/05/2003  - Welcome to Foamix